Member Info for icalvert

Thanks very much for the official CRUK news about January.

Does anyone know anything about the nebulous cunning planning for a referendum about a referendum? I guess it's a secret.

Happy Christmas and New Year!

Sincere best wishes and good luck.

At the risk of being accused of ramping South London NHS hospitals : St. Thomas and Guy's are confidence inspiring too. I fell over and had hand surgery on my little finger.

I guess the UK sites for Scancell clinical trials like most things are important but not very?

Thanks, crumbs.

On the 8 mg SCIB1+ Keytruda trial, will the UK -USA composition of the 6 patient safety run-in remain a secret?

I agree...but IF the BoD have more cash than appropriate (risky) asset increases maybe as a possible option they should consider purchasing derivatives to protect future cashflows as well as dividends?

Should Scancell produce an RNS listing lots of good reasons why the share price has risen 15% this morning?

D'oh

Sent before the punchline about FDA and regulators of UK sites!

Yesterday was a good thing but tomorrows world will be better.

Konar

RNS tomorrow, i do hope so.

Maybe a reaffirmation of Scancell's USA strategy until 2020(say) might be tacked on?

inanaco the wise,

On the Scib1-Trigrid 2- PD-1 trial , i had assumed rather than go immediately to 4mg or 8 mg there would be a ramp up for safety reasons.

However I haven't the slightest idea what might currently concern the FDA about this USA-UK trial.

Please will you or others speculate.

"Scancell and Ichor are working with the FDA to provide the necessary information to enable initiation of the trial. In parallel, Scancell is continuing to work on the operational activities required to initiate clinical sites in the US and UK."

In the unlikely event, of significant FDA delay , I guess this trial could proceed in the UK only?

researcher1,

Me too, I hope for Christmas rather than January!

I hope to attend the AGM and am interested in the number of Modi products that might eventually be produced for patients.

I think i understand the great hopes for Modi 1 ,2 and 3 but...

Does Scancell or anyone here have any evidence,from say humanised mice, that the theorectical hopes will be realised?

Doubtless good news about non-execs.

Are POX processing deals likely with other Russian parties at all likely before 2020?

RayPointer

Great post about high place Scancell is at scientifically and also with CRUK and other collaborators.

However what is your vision for how a possibly large number of MODI N trials will be financed quickly?

As we patient shareholders wait hungrily for patient successes, i can't help thinking that an RNS on Moditope successes with humanised mice might help the SP.

Does anyone have a subjective probability for Lindy's team winning the CRUK Grand Challenge?

Has this increased because there is no RNS??

Please excuse my lack of attention earlier but....

I vaguely recall some time ago collaborative work with/for a brain cancer charity was announced.

I assumed this might be a Modi-n product but has there been any RNS after the initial one?

D'oh

Sorry, I was just putting in a good word in this community for a Wolfram product I use, after nomlugu's post.

For what its worth, Wolfram Mathematica is , for me , wonderful mathematical software . I am a retired Ph.d mathematician. I have been using it (version 10.2) recently for mathematical work on a presentation about risk strategies for team players,

The wider system has much grander than mathematical ambitions . I would guess "might well" might be appropriate.

On a less serious note, maybe any RNS on Moditope would help the incredibly flattish share price?